3.785
price up icon3.33%   0.1221
after-market Dopo l'orario di chiusura: 3.79 0.005 +0.13%
loading

Xenetic Biosciences Inc Borsa (XBIO) Ultime notizie

pulisher
Oct 31, 2024

Xenetic Biosciences announces board member changes - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

Xenetic Biosciences announces board member changes By Investing.com - Investing.com UK

Oct 31, 2024
pulisher
Oct 26, 2024

Short Interest in Xenetic Biosciences Inc (NASDAQ:XBIO) Grows By 460.0% - Defense World

Oct 26, 2024
pulisher
Oct 22, 2024

Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2024 - AccessWire

Oct 22, 2024
pulisher
Oct 21, 2024

SEC Form S-3 filed by Xenetic Biosciences Inc. - Quantisnow

Oct 21, 2024
pulisher
Oct 17, 2024

Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform - AccessWire

Oct 17, 2024
pulisher
Oct 17, 2024

Xenetic partners with Tokyo Medical for cancer treatment study - Investing.com

Oct 17, 2024
pulisher
Oct 16, 2024

Secondary Progressive Multiple Sclerosis Drug Market to Expand with Significant CAGR by 2034 |AB Science SA, Actelion Lt – IndiaPolitics.com - IndiaPolitics.com

Oct 16, 2024
pulisher
Oct 13, 2024

Short Interest in Xenetic Biosciences Inc (NASDAQ:XBIO) Drops By 50.0% - Defense World

Oct 13, 2024
pulisher
Sep 13, 2024

Xenetic Biosciences Inc (NASDAQ:XBIO) Sees Significant Decline in Short Interest - Defense World

Sep 13, 2024
pulisher
Sep 11, 2024

Xenetic Biosciences, Inc. Presents at the H.C. Wainwright 26th Annual Global Investment Conference - Kansas City Star

Sep 11, 2024
pulisher
Aug 22, 2024

Q3 2024 Earnings Estimate for Xenetic Biosciences Inc (NASDAQ:XBIO) Issued By HC Wainwright - Defense World

Aug 22, 2024
pulisher
Aug 21, 2024

XBIO Stock Earnings: Xenetic Biosciences Meets EPS, Beats Revenue for Q2 2024 - MSN

Aug 21, 2024
pulisher
Aug 21, 2024

Xenetic Biosciences (NASDAQ:XBIOW) Stock Price Up 33.9% - Defense World

Aug 21, 2024
pulisher
Aug 20, 2024

Xenetic Biosciences (XBIO) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 20, 2024
pulisher
Aug 20, 2024

Xenetic Biosciences (NASDAQ:XBIO) Earns “Neutral” Rating from HC Wainwright - Defense World

Aug 20, 2024
pulisher
Aug 18, 2024

Xenetic Biosciences Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line - Simply Wall St

Aug 18, 2024
pulisher
Aug 16, 2024

Xenetic Biosciences (NASDAQ:XBIO) Releases Earnings Results, Hits Estimates - Defense World

Aug 16, 2024
pulisher
Aug 14, 2024

Xenetic Biosciences, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update - Markets Insider

Aug 14, 2024
pulisher
Aug 14, 2024

Xenetic Biosciences: Q2 Earnings Snapshot - CTPost

Aug 14, 2024
pulisher
Aug 13, 2024

Xenetic Biosciences Inc (NASDAQ:XBIO) Short Interest Up 3,550.0% in July - Defense World

Aug 13, 2024
pulisher
Aug 07, 2024

ElectroCore, Inc. (ECOR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Canada Finance

Aug 07, 2024
pulisher
Aug 06, 2024

Xenetic Biosciences stock hits 52-week low at $2.78 By Investing.com - Investing.com Canada

Aug 06, 2024
pulisher
Aug 06, 2024

Xenetic Biosciences stock hits 52-week low at $2.78 - Investing.com India

Aug 06, 2024
pulisher
Aug 03, 2024

Takeda Pharmaceutical (TAK) Stock Price, News & Analysis - MarketBeat

Aug 03, 2024
pulisher
Jul 30, 2024

Global Chronic Kidney Disease (CKD) Drug Market 2024 Analysis by Top Key Players |Abbott Laboratories - The NRI News

Jul 30, 2024
pulisher
Jul 27, 2024

CANADA LIFE ASSURANCE Co Grows Stock Position in Tapestry, Inc. (NYSE:TPR) - American Banking and Market News

Jul 27, 2024
pulisher
Jul 26, 2024

Xenetic Biosciences Inc (NASDAQ:XBIO) Short Interest Down 93.0% in July - Defense World

Jul 26, 2024
pulisher
Jul 19, 2024

Xenetic Biosciences, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results - Quantisnow

Jul 19, 2024
pulisher
Jul 13, 2024

WiMi Hologram Cloud Inc. (NASDAQ:WIMI) Sees Large Growth in Short Interest - Defense World

Jul 13, 2024
pulisher
Jul 13, 2024

Short Interest in Wearable Devices Ltd. (NASDAQ:WLDS) Declines By 51.0% - American Banking and Market News

Jul 13, 2024
pulisher
Jul 13, 2024

Short Interest in Xenetic Biosciences Inc (NASDAQ:XBIO) Decreases By 18.1% - American Banking and Market News

Jul 13, 2024
pulisher
Jul 13, 2024

Welsbach Technology Metals Acquisition Corp. (NASDAQ:WTMA) Short Interest Update - American Banking and Market News

Jul 13, 2024
pulisher
Jul 13, 2024

Bird Construction Inc. (OTCMKTS:BIRDF) Short Interest Update - American Banking and Market News

Jul 13, 2024
pulisher
Jul 07, 2024

(XBIOW) Trading Advice - Stock Traders Daily

Jul 07, 2024
pulisher
Jul 07, 2024

Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference - Quantisnow

Jul 07, 2024
pulisher
Jul 07, 2024

Xenetic Biosciences, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update - Quantisnow

Jul 07, 2024
pulisher
Jul 06, 2024

Xenetic Biosciences (NASDAQ:XBIOW) Trading Up 17.5% - Defense World

Jul 06, 2024
pulisher
Jun 29, 2024

Xenetic Biosciences (XBIO) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Sport Australia

Jun 29, 2024
pulisher
Jun 28, 2024

Long Term Trading Analysis for (XBIOW) - Stock Traders Daily

Jun 28, 2024
pulisher
Jun 28, 2024

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference - Quantisnow

Jun 28, 2024
pulisher
Jun 22, 2024

VAXART, INC. (VXRT) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Lifestyle Australia

Jun 22, 2024
pulisher
Jun 21, 2024

Xenetic Biosciences reports management changes and compensatory arrangements By Investing.com - Investing.com

Jun 21, 2024
pulisher
Jun 21, 2024

Xenetic Biosciences Announces Executive Leadership RestructuringTipRanks.com - TipRanks

Jun 21, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):